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Abstract: The prevention of the posterior capsule opacification is still unsolved. To interfere with proliferating cells the 
T-type calcium channel antagonist Mibefradil was immobilized in poly-lactic-co-glycolic-acid micro particles which were 
fixed at a capsular tension ring and tested in a human organ culture model as well as in human lens cells HLE-B3 in vitro. 
It is feasible to get a release significantly affecting cell viability and growth evaluated by MTT test and cell cycle analysis. 
In addition, Bionas
® sensor chips were used for time-dependent adhesion experiments in living lens cells. Interestingly, 
the concentration of Mibefradil which inhibited subconfluent cells is not effective in confluent cells. This is an important 
feature for the protection of the intact tissue in the eye. 
Keywords: Calcium channel antagonist Mibefradil, lens epithelial cell adhesion, PLGA micro particles, organ culture model. 
INTRODUCTION 
  Posterior capsule opacification (PCO) is still the major 
complication in cataract surgery in consequence of an activa-
tion of lens epithelial cells due to surgery [1-4] that involves 
cell phenotype changes [5], increased matrix production, 
proliferation and migration [6,7]. To date, most of the phar-
macological drugs which have been therapeutically applied 
to block opacification [8] are limited in use due to serious 
damage of the surrounding tissues in the eye [9]. Interesting 
investigations concerning stress response of lens cells in the 
closed capsular bag in vitro were made by Duncan [10] using 
thapsigargin, hyperosmotic NaCl or distilled water as hy-
posmotic stress. The mechanism of action of thapsigargin is 
to disable calcium signalling by depleting the ER calcium 
store, thus leading to cell cycle arrest [10]. This is different 
from the cellular influence of the other tested solutions. Ad-
vances in the prevention of PCO have been made concerning 
the geometry of the intraocular lenses [11], thus sharp edged 
lenses were able to diminish the migration of lens cells [12, 
13]. At least, this technique is not able to solve the long term 
problem of PCO [14]. 
  The challenge of a suitable therapy to inhibit capsule 
opacification could be to specifically interfere with cellular 
adhesion mechanisms in outgrowing lens epithelial cells. 
The focus is also on the calcium signalling pathway. Our 
approach using the T-type calcium channel antagonist Mibe-
fradil is based on the hypothesis that this drug could prevent  
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cellular adhesion and function due to an inhibition of the 
calcium entry into the cell. An inhibition of the calcium en-
try was not only found for platelet cells [15] but we also pro-
vide evidence that our primary human lens epithelial cells in 
the cell culture express T-type calcium channels [16,17] as 
well as potassium channels [16-18], which were influenced 
by Mibefradil. Our previous studies demonstrated that cul-
tured primary human lens epithelial cells which grew out 
from anterior capsules obtained from patients after cataract 
surgery detached from the tissue culture plastic due to incu-
bation with Mibefradil. This was concentration dependent 
accompanied by structural changes of extracellular matrix 
proteins, fragmented actin cytoskeleton, and an altered orga-
nization of 1-integrin receptors as well as their reduced 
expression [16,18-20] as summarized in Fig. (1). All these 
findings suggest specific actions induced by Mibefradil. Our 
new studies were focused on (i) the inhibitory effect of 
Mibefradil especially on outgrowing cells (i.e. subconfluent), 
(ii) on a practicable approach to immobilize this drug in mi-
cro particles by modifying a solvent evaporation procedure 
with a constant release during a longer period, and (iii) to 
affix these particles on a capsular tension ring to test the in-
hibitory influence on the cell’s outgrowth in an organ culture 
model. 
MATERIALS AND METHODOLOGY 
Calcium Channel Antagonist and Immobilization Proce-
dure 
  The T-type calcium channel blocker Mibefradil (1S,2S)-2-
[2-[[3-(2-benzimidazolyl propyl] methyl amino] ethyl]-6-
fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl-methoxy ace-
tate dihydro-chloride) (Sigma) [7,22,15] was solubilized in Lens Epithelial Cell Growth Prevention  The Open Ophthalmology Journal, 2008, Volume 2    113 
distilled water (stock solution 50 mg/10 ml) for cell culture 
experiments. The stock solution was stored at 4 °C. There are 
no commercial relationships between Sigma and our depart-
ment of cell biology. 
 
Fig. (1). Schematic representation summarizing the effect of the T-
calcium channel blocker Mibefradil on human lens epithelial cells 
found in our basic in vitro cell culture experiments: a. Membrane 
potential depolarized, b. Integrin expression reduced, integrins clus-
tered, c. Extracellular matrix proteins clustered, d. Actin cytoskele-
ton fragmented, vimentin structure altered, e. Opening of the tight 
junctions  ZO-1 translocation to the cytoplasm, f. Apoptosis  Bax 
translocation to the mitochondria, g. Apoptosis  phosphatidylser-
ine switch, h. Apoptosis  DNA cleavage. 
  Spherical PLGA (poly-lactic-co-glycolic-acid) micro 
particles were used for immobilization of Mibefradil dihy-
drochloride. Mibefradil containing micro particles were pre-
pared by modifying a solvent evaporation procedure using 
ethyl acetate as dispersing solvent [23]. These micro cap-
sules released the active agent with a daily average of 7.5 
mg/l during a period of 50 days [24,25]. The micro particles 
were coupled on the PMMA (polymethyl methacrylate) sur-
face of the capsular tension ring (Micromod Partikeltech-
nologie GmbH) [25] which contain 38  mg Mibefradil per 
gram. The total amount of Mibefradil on a capsular tension 
ring corresponds to a final concentration of 10, 20 und 
30 M after 24 h. 
Scanning Electron Microscopy 
  Cells cultured on cover slips were fixed with 4 % glu-
taraldehyde and dehydrated through a grade series of ace-
tone. After critical point drying (Emitech K850, Emitech) 
and sputter-coating with gold (SCD 004, BAL-TEC), sam-
ples were examined using a scanning electron microscope 
DSM 960A (Carl Zeiss) at an accelerating voltage of 10 kV. 
Transmission Electron Microscopy 
  Samples were fixed with 4 % glutaraldehyde, postfixed 
in 1 % buffered osmiumtetraoxide (OsO4) followed by dehy-
dration through a graduated series of acetone and embedded 
in epoxy resin araldite. Ultra-thin sections were prepared 
with an ultramicrotome (Ultratom III, LKB or Ultracut SWS, 
Leica), stained with uranyl acetate and citrate and then ex-
amined in the transmission electron microscope EM 902 
(Carl Zeiss). Digital pictures were made by the CCD camera 
(Proscan) using the EFTEM software (Olympus Soft Imag-
ing Solutions). 
Cell Culture of Human Lens Epithelial Cells 
  The immortalized human lens epithelial cells HLE-B3 
(ATCC No: CRL-11421) were cultivated in tissue culture 
flasks (25  cm
2, Greiner Bio-One) in Dulbecco’s modified 
Eagle medium (DMEM, Invitrogen) with 10  % fetal calf 
serum (FCS), 4500 mg/l glucose (high glucose), GlutaMAX, 
pyruvate and 1 % gentamicin (Gibco Invitrogen) at 37 °C 
and in a 5 % CO2 atmosphere. 
Organ Culture Model 
  The human phacocyst (capsular bag) was excised post 
mortem as recommended by Priglinger [26] and the lenticu-
lar cortex and nucleus was eliminated. This organ culture 
model should simulate conditions in vivo due to similar 
physiological circumstances. The phacocyst was cultivated 
in DMEM with 0.5 % FCS and 1 % gentamicin for 20 days 
before the pharmacologically modified micro particles were 
inserted and the Mibefradil released over 24 h. 
Cell Vitality Analysis 
  The inhibitory influence of Mibefradil-containing micro 
particles (concentrations 10, 20, 30 M, after 24 h) was stud-
ied by measuring lens cell’s metabolism (methyl thiazolil tet-
racolium test, MTT test
®, Roche). The principle of the test is 
an enzymatic cleavage of the tetracolium salt 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) 
by active cells into water insoluble violet salt crystals. The 
spectrophotometric absorption was analyzed by an ELISA 
reader (Anthos 2010, Anthos Labtec Instruments) at 590 nm. 
The extinction is proportional to the metabolic activity of the 
cells. The MTT test was used for HLE-B3 lens cells as well as 
for the primary cells in the capsular bag as organ culture 
model. HLE-B3 cells were cultured in 24-well plates and in-
cubated for 24 h with Mibefradil containing micro particles 
using release-concentrations of 10, 20, and 30 M. Primary 
cells of the capsular bag were incubated with Mibefradil simi-
larly. 
  The cell survival was studied by live/dead-viability test 
(Molecular Probes). HLE-B3 cells were cultured for 24 h in 
6-well plates with tissue culture inserts (Thin Cert, pore size 
0.4 m, Greiner Bio-One) where Mibefradil containing mi-
cro particles were placed. Staining of the cells was per-
formed according to the manufacturer’s instructions. Calcein 
stains living cells (green fluorescence) whereas ethidium 
homodimer indicates dead cells (red fluorescence). Light 
microscopy (Axiovert 25, Carl Zeiss) and laser scanning 
confocal microscopy (LSM 410, objective 40x/0.6, LD 
Acroplan ph2, Carl Zeiss) were used for the observations. 
Cell Cycle Analysis and Apoptosis 
  The HLE-B3 cells were cultured in 6-well plates. Mibe-
fradil containing micro particles were placed on culture in-
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6-well plates. The Mibefradil release corresponded to con-
centrations of 10, 20, and 30 M. Incubation time was 24 h. 
For flow cytometry, HLE-B3 cells were suspended using 
0.05  % trypsin/0.02  % EDTA solution (5  min at 37  °C). 
Then, cells were washed in phosphate buffered saline (PBS), 
fixed with 70 % ethanol over night at -20 °C, and intensively 
washed again. After treatment with 1 % RNase (Sigma) for 
20  min at 37  °C, the DNA of the cells was labelled with 
propidium iodide (50 g/ml, Sigma) over night at 4 °C. Cells 
were measured in a FACSCalibur
TM flow cytometer (BD 
Biosciences) equipped with a 488 nm argon-ion laser and a 
Macintosh Power PC (G4). In general, 25,000 events were 
acquired using CellQuest Pro 4.0.1. Proliferating cells (i.e. 
cells in S- and G2-phase of the cell cycle) and apoptotic cells 
(sub-G1 peak of the DNA histogram) were then calculated in 
percent using ModFIT version 3.0 (BD Biosciences). 
Adhesion of Living Lens Cells 
  Time dependent adhesion experiments with subconfluent 
and confluent living HLE-B3 cells were carried out using 
Bionas
® sensor chips for adhesion (Bionas GmbH, Rostock). 
The sensory component was impedance measurements with 
interdigitated electrode structures (IDES). The impedance 
and conductance (i.e. the ability of a material to pass elec-
trons) correlates with the adhesion of cells [27,28]. The 
IDES sensor structure on the silicon chip consists of gold. 
The sensor chips were cleaned and sterilized with 70  % 
ethanol for 10 min and rinsed with DMEM before HLE-B3 
cells were disseminated. For a subconfluent monolayer 8 x 
10
4 cells/chip were cultured for 24  h, and for a confluent 
monolayer 1.5 x 10
5 cells/chip were cultured for 42  h in 
DMEM as describe above. Then, the cells grown on the chip 
surface were incubated with the substance Mibefradil at con-
centrations of 10, 20, 30 M for 24 h and the physical pa-
rameters conductance and impedance were measured in the 
Bionas 2500 instrument (Bionas
® GmbH) with the software 
Bionas
® 2500 SW 1.15. There are no commercial relation-
ships between Bionas
® GmbH and our department of cell 
biology. 
Statistical Analysis 
  Statistical analysis was performed with SPSS 14.0 for 
Windows (SPSS Inc., Chicago, IL). The differences between 
the concentrations were evaluated using Students t-test for 
independent samples because variables present normal dis-
tribution (Kolmogorov-Smirnov test). Data were indicated as 
mean and standard error of the mean. Significance was set at 
p < 0.05. 
RESULTS 
  In our new experiments we were interested in both, the 
time-dependent influence of Mibefradil on cell adhesion in 
subconfluent and confluent living cells in vitro and, we 
wanted to solve the question if this drug can be immobilized 
in PLGA micro particles which were then affixed at a capsu-
lar tension ring as a practicable approach. 
  For time-dependent adhesion analysis cells were grown 
on the sensor chips as seen in Fig. (2). The physical parame-
ter impedance was measured with the adhesion sensor. This 
impedance signal correlates with the density of the cell mon-
olayer during the experiment as well as with the adhesion 
behavior of the cells such as the spatial proximity of the cell 
membrane to the electrode and cell morphology like the cell-
cell-connections (tight junctions). We revealed that the cal-
cium channel blocker Mibefradil induced a loss of cell adhe-
sion (Fig. 3a). In subconfluent lens cells, we observed a 
clearly decrease at 30-40 % already after 2 h of Mibefradil 
incubation with 20 and 30  M followed by a nearly total 
inhibition after 20 h demonstrating the loss of adhesion. This 
is in contrast to confluent cells (Fig. 3b). In confluent cells, 
the cell monolayer is without any gaps in between the cells, 
therefore Mibefradil significantly influences the cell adhe-
sion first at 18 h and only in the highest concentration of 
30 M. It is obviously, that Mibefradil’s influence is more 
intensive in proliferating lens epithelial cells (according to 
the subconfluent state in the cell culture). 
 
Fig. (2). a: HLE-B3 lens epithelial cells grown on Bionas
® sensor 
chips for adhesion experiments in living cells (microscope Olympus 
BX51M, software Olympus DP-soft, camera Olympus Camedia 
C4040). The white insert is magnified in the SEM image below. b: 
Scanning electron microscopy of HLE-B3 on the sensor chip. Lens Epithelial Cell Growth Prevention  The Open Ophthalmology Journal, 2008, Volume 2    115 
 
Fig. (3). a: Time-dependent loss of adhesion of living subconfluent 
HLE-B3 lens epithelial cells on Bionas
® sensor chips. Note that in 
subconfluent cells, 20 and 30 M Mibefradil induced a clearly de-
crease of cell’s adhesion capacity already after 2 h (* p<0.05, 4 h 
** p<0.01, 6 h *** p<0.001) compared to the untreated control and, 
reached a nearly total inhibition after 20 h. Bionas 2500 instrument 
(Bionas
®  GmbH).  b: The influence of Mibefradil on confluent 
HLE-B3 lens epithelial cells is negligible. Here, only Mibefradil in 
the highest concentration (30 M) inhibited cell adhesion first after 
18 h (* p<0.05). The lower Mibefradil concentrations revealed no 
effect on living cell adhesion during the observed time frame. 
  The capsule tension ring with the affixed spherical PLGA 
micro particles which were loaded with Mibefradil is dem-
onstrated in Fig. (4). The substructure of the micro particles 
is shown in the corresponding SEM- (Fig. 4c) and TEM-
images (Fig. 4d). The emulsifying agent embeds the sub-
stance into small vesicles. Formation of PLGA and the form 
of spheric micro particles like in the TEM-image results 
from dehumidifying of the organic phase of the emulsifying 
agent. We wanted to know if Mibefradil incorporated in mi-
cro particles has the same cell inhibitory influence compared 
to the solved substance. In the cell analysis tests we can 
demonstrate that the release behavior of Mibefradil is effec-
tive with a daily average of 7.5 mg/ml of the active agent 
during a period of 50 days. More than 15 mg/ml of the sub-
stance was released into the medium during the first 24 h 
(personal communication J. Teller and [25]). The MTT 
analysis in Fig. (5) shows a reduction of the metabolic activ-
ity of HLE-B3 lens epithelial cells after the 24 h-incubation 
with Mibefradil-loaded particles (p<0.001). Flow cytometric 
measurements in Fig. (6)  demonstrate that the  synthesis 
phase (S) and the G2/M phase of the cell cycle of HLE-B3 
lens cells are significantly reduced, and apoptosis in the late 
stage was induced due to Mibefradil immobilized in the   
 
 
Fig. (4). a: Spheric PLGA micro particles loaded with Mibefradil 
(Canon Powershot G6 Digicam, 4x optical zoom). b: Capsule ten-
sion ring with fixed spheric PLGA micro particles loaded with 
Mibefradil. The indicated area is seen in the next image below. c: 
Magnified view of the indicated area (in b) of the tension ring: 
scanning electron microscopic image of Mibefradil containing 
PLGA micro particles. d: Transmission electron microscopic image 
of Mibefradil containing PLGA micro particles. 116    The Open Ophthalmology Journal, 2008, Volume 2  Weidmann et al. 
 
Fig. (5). The metabolic activity (MTT test) of cultured HLE-B3 
lens epithelial cells is significantly reduced after the 24 h-release of 
Mibefradil immobilized in micro particles (p<0.001). 
 
Fig. (6). The synthesis phase (S) and the G2/M phase of the cell 
cycle of HLE-B3 lens epithelial cells is significantly reduced, and 
apoptosis in the late stage was induced after the 24  h-release of 
Mibefradil (20, 30  M) immobilized in micro particles (n=6, 
* p<0.05, ** p<0.01, *** p<0.001). Flow cytometry. 
 
Fig. (7). Live/dead viability test of HLE-B3 lens epithelial cells 
incubated with Mibefradil-containing micro particles after 24  h. 
Almost all cells of the control as well as of the Mibefradil concen-
tration 10 M seem to be alive (green), whereas incubation with 20 
and 30 M Mibefradil resulted in cell dead in these subconfluent 
growing cells (red). 
PLGA particles (20, 30 M) (p<0.05). In addition, Mibefra-
dil in release concentrations of 20 and 30 M results in a 
massive cell disturbance and loss of vitality (Fig. 7). 
  In Fig. (8) we demonstrate the human capsular bag (Fig. 
8a) which was used as an organ culture model for the place-
ment of the capsule tension ring (Fig. 8b). After 21 days of 
cultivation time of the organ culture, in controls the cells 
grow out and reveal a well spread morphology (Fig. 8c). In 
contrast, the morphology of Mibefradil (30 M) treated lens 
cells in the capsular bag (Fig. 8d) is completely different – 
the cell area is small and neighbouring cells lost their cell-
cell-contacts. In addition, the metabolism of outgrowing 
primary human lens cells in the organ culture model (Fig. 9) 
is significantly decreased after a 24  h-release (10, 20  M: 
p<0.05 and 30 M: p<0.001) of Mibefradil-containing micro 
particles which were fixed at the capsular tension ring. 
 
Fig. (8). a: The capsular bag as a human organ culture model in 
vitro. b: Capsular bag with a normal capsule tension ring. c: Mor-
phology of untreated, well spread human lens cells after 21 d in the 
organ culture model (microscopic images, 10x). d: Morphology of 
lens cells after treatment with Mibefradil-containing micro particles 
(30 M) after 21 d in the organ culture model (microscopic images, 
20x). Note that the cell area is reduced and neighbouring cells lost 
their cell-cell-contacts. 
 
Fig. (9). The metabolism of primary human lens epithelial cells in 
the organ culture model demonstrates a significant decrease after 
21 d culture with a Mibefradil containing capsular tension ring at 
the range of 10, 20 and 30 M (* p<0.05, *** p<0.001). 
DISCUSSION 
  In our earlier investigations concerning the influence of 
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human lens epithelial cells in a monolayer cell culture we 
found out changes in the expression of integrin receptors 
[18] and the induction of apoptosis [16]. Reduced integrin 
expression leads to reduced adhesion as could be found e.g. 
in leucocytes [29,30]. Here, in our new experiments concern-
ing time dependent cell adhesion with living human lens 
epithelial cells (HLE-B3) on adhesion sensor chips we re-
vealed a reduced adhesion, e.g. the conductance and imped-
ance values were diminished which is an indicator for the 
loss of cell’s contact area to the surface of the sensor. Inter-
estingly, the concentration of the drug which effectively in-
hibits cell adhesion in subconfluent cells on the adhesion 
chips is not effective in confluent cells. One explanation for 
this important feature to inhibit only growing lens cells could 
be the role for T-type calcium channels in cell proliferation 
[31], as shown for example in fibroblasts [32] and in smooth 
muscle cells [33]. In these studies a pharmacological block-
ade of T-type channels completely inhibited proliferation 
and it could be found that the T-type voltage-operated cal-
cium channels are required for the cell cycle progression and 
proliferation [33]. Otherwise, over-expression of a subunit of 
the T-channel led to a growth advantage in HEK-293 cells 
[34]. Our primary human lens epithelial cells as well as the 
lens epithelial cell line HLE-B3, both express calcium chan-
nels of the T-type, as we could demonstrated earlier for the 
first time [16,17]. Further experiments have to discover the 
expression differences of T-type channels in subconfluent 
versus confluent lens epithelial cells to finally conclude that 
the observed higher sensitivity to Mibefradil in subconfluent 
cells correlates with their calcium channel expression. To 
interfere only with the outgrowing, proliferating cells is an 
important feature for the protection of the intact collateral 
tissue in the eye [9] and offers possibilities in the specifically 
pharmacological intervention in the secondary cataract. Until 
now the use of pharmacological substances like cytostatic 
drugs and immunotoxins has been limited because of dam-
ages also of the surrounding tissues due to general toxic ef-
fects [35-37]. Mibefradil as T-channel inhibitor interfered 
especially with growing HLE-B3 cells expressing higher Cav 
3.1 and 3.3 levels [17]. Therefore, the toxicity for the sur-
rounding tissue is possibly not to expect in the therapeutic 
concentrations used for the prevention of lens epithelial out-
growth. In this context it is noteworthy that the substance 
Mibefradil, accredited in Germany 1997, was withdrawn 
from the market [38] because of interactions with the cyto-
chrome p450 system of the liver. Mibefradil in combination 
with other pharmaceuticals in the antihypertensive therapy 
especially beta blockers, led to cross reactions and followed 
complications in patients. However, Mibefradil dihydro-
chloride is interesting as T-channel blocker substance with a 
specific antiadhesive and antiproliferative properties differ-
ent from existing calcium channel blockers such as Verapa-
mil (L-type blocker) [17] or Ethosuximid (T-type blocker) 
(still unpublished data from contemporary experiments). 
  A capsular tension ring is used in cases undergoing in-
traocular lens implantation and it could be evaluated a safety 
and efficacy use associated with a reduced incidence of pos-
terior capsular opacity [39]. We suggest that our pharmaco-
logically modified capsular tension ring has the potential to 
prevent the migration of residual lens epithelial cells. There-
fore, animal experiments have to evaluate the practicability 
of this new method to prevent postoperative cataract in vivo. 
CONCLUSION 
  The T-type-calcium channel blocker Mibefradil specifi-
cally interfere with outgrowing cells, which corresponds to a 
subconfluent cell culture. It is feasible to encapsulate the 
calcium channel blocker Mibefradil in PLGA micro parti-
cles, to immobilize the micro particles at the capsular tension 
ring consisting of PMMA and to get a release behavior of 
Mibefradil significantly effecting cell viability and growth. 
Our new approach using Mibefradil containing micro parti-
cles with a continuously released agent seems to be practica-
ble to prevent cataracta secundaria. 
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